Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non-small cell lung cancer

  • Sun Ha Choi
  • , Sook Kyung Do
  • , Shin Yup Lee
  • , Jin Eun Choi
  • , Hyo Gyoung Kang
  • , Mi Jeong Hong
  • , Jang Hyuck Lee
  • , Won Kee Lee
  • , Ji Yun Jeong
  • , Kyung Min Shin
  • , Young Woo Do
  • , Eung Bae Lee
  • , Ji Eun Park
  • , Yong Hoon Lee
  • , Hyewon Seo
  • , Seung Soo Yoo
  • , Jaehee Lee
  • , Seung Ick Cha
  • , Chang Ho Kim
  • , Jae Yong Park

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science